AcquisitionsApr 27, 2026, 04:35 PM
PFSA Acquires Bio Insights' PanOmics Platform for $30M
AI Summary
Profusa Inc. is acquiring substantially all know-how assets related to Bio Insights LLC's PanOmics Platform, an integrated multi-omics analysis platform, for $30 million. The consideration will be paid through the issuance of non-voting Series A Convertible Preferred Stock, convertible into common stock after one year and subject to a five-year lock-up. Additionally, Profusa will allocate up to $2 million for PanOmics operating cash and aims to raise $10 million in new equity financing.
Key Highlights
- Profusa Inc. acquires substantially all know-how assets related to Bio Insights LLC's PanOmics Platform.
- Purchase price is $30,000,000, satisfied by issuing Series A Convertible Preferred Stock.
- Preferred Stock is non-voting, convertible to common stock after one year, subject to a 4.9% beneficial ownership limit.
- Securities are subject to a 5-year lock-up period, released ratably over four years.
- Seller will receive a 3% royalty on revenue derived from the commercialization of the PanOmics Assay.
- Profusa will allocate up to $2,000,000 from equity financings for PanOmics Assay validation and capital equipment.
- Buyer's management to receive 12% of fully diluted common stock, subject to shareholder approval.
- Buyer aims to raise $10,000,000 in additional equity financing contemporaneous with or within 30 days of closing.